Severe COVID-19 patients tend to show elevated circulating amounts of the proinflammatory mediators Interleukin-6 (IL-6), IL-8, IL-1β, and Monocyte Chemoattractant Protein-1 (MCP-1) (5). This evidence concerns the gene CCL2 and COVID-19.